Trial Condition(s):

Colorectal Neoplasms

EffectiveNess of low dose Aspirin in GastrointEstinal cancer prevention - Taiwan (ENgAGE-Taiwan)

Bayer Identifier:

19882

ClinicalTrials.gov Identifier:

NCT03579732

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The study evaluates the protective effect of low-dose aspirin use on gastrointestinal cancers (colorectal, esophageal and gastric cancers) in long-term users, episodic users and non-users of aspirin in Taiwan.

Inclusion Criteria
- Age 40 or older at the cohort entry date.
                - Taiwanese National Health Insurance enrollees with non-missing and consistent age and gender information.
Exclusion Criteria
- Subjects with any cancer diagnosis before cohort entry date.
                - No use of National Health Insurance before the cohort entry date.
                - Low dose aspirin prescription before cohort entry date.
                - Subjects with conditions contra-indicated for low dose aspirin use before cohort entry date.

Trial Summary

Enrollment Goal
4710504
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Aspirin (Acetylsalicylic Acid, BAYE4465)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

National University of Taiwan Hospital

Taipeh, Taiwan, China, 100

Status
Completed
 

Trial Design